What You Should Know: – Nebula Genomics announces integration with Oasis Labs to give its customers full ownership and control of the data received from their comprehensive genome sequencing tests. – Through Oasis Labs’ unique privacy solution Parcel, Nebula’s users will be able to retain… Read More »Nebula Gives Users Ownership Of Their Personal Genomic Data with Oasis Integration
Swiss medical data specialist Sophia Genetics has raised $110 million in an oversubscribed funding round that will be used to boost its headcount and international presence and prepare to take its shares public. Proceeds from the sixth-round of private fundraising will fund the growth in… Read More »$110m financing sets up US, Asia expansion for Sophia Genetics
Renee Yao, Global Healthcare AI Startups Lead at NVIDIA COVID-19 has put a tremendous burden on hospitals, and the clinicians, nurses, and medical staff who make them run. Many hospitals have suffered financially as they did not anticipate the severity of the disease. The extended… Read More »4 Areas Driving AI Adoption in Hospital Operations and Patient Safety
Bionano Genomics Acquires Lineagen to Facilitate the Clinical Adoption of Saphyr for Digital Cytogenetics
Shots: Lineagen to receive $9.6M consisting of 6,167,510 shares of Bionano’s common stock, ~ $1.7M in cash and assumption of ~$2.9M in liabilities. The acquisition complements Binano by adding leading cytogeneticists, genetic counselors, laboratory operations and billing experts, clinical commercialization experts, and payor contracts The… Read More »Bionano Genomics Acquires Lineagen to Facilitate the Clinical Adoption of Saphyr for Digital Cytogenetics
What You Should Know: – CancerIQ raises $5M in Series A funding led by HealthXVentures to accelerate the growth of its genetic cancer risk assessment platform to identify and manage patients at high risk of cancer. – CancerIQ’s technology enables hospitals to use genomics to… Read More »CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform
The Chicago-based startup company plans to use the funding to further growth of its product offering and integration with EHRs and genetic testing partners.
Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more than 1,000 hospitals around the world to try to work out how the COVID-19 pandemic will evolve in the coming months and years. The data mining tool… Read More »Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of July 2020. While a pandemic ravages the country, technology valuations are soaring. The Nasdaq hit an all-time high during the month of… Read More »Analysis: July Health IT M&A Activity; Public Company Performance
The new report, from the University of Pittsburgh Medical Center’s Center for Connected Medicine, surveyed 101 representatives of hospitals and healthcare systems. Nine out of 10 respondents said they were providing genomic or genetic testing or planning to.
A Q&A with executives from Seven Bridges, a bioinformatics analysis business, highlights the company’s work in the precision medicine sector.